270 related articles for article (PubMed ID: 23532566)
1. Yeast-incorporated gallium attenuates glucocorticoid-induced bone loss in rats by inhibition of bone resorption.
Ren Z; Yang L; Xue F; Meng Q; Wang K; Wu X; Ji C; Jiang T; Liu D; Zhou L; Zhang J; Fu Q
Biol Trace Elem Res; 2013 Jun; 152(3):396-402. PubMed ID: 23532566
[TBL] [Abstract][Full Text] [Related]
2. Liraglutide increases bone formation and inhibits bone resorption in rats with glucocorticoid-induced osteoporosis.
Yang L; Yang J; Pan T; Zhong X
J Endocrinol Invest; 2019 Sep; 42(9):1125-1131. PubMed ID: 30955181
[TBL] [Abstract][Full Text] [Related]
3. Effects of the combined Herba Epimedii and Fructus Ligustri Lucidi on bone turnover and TGF-β1/Smads pathway in GIOP rats.
Yang Y; Nian H; Tang X; Wang X; Liu R
J Ethnopharmacol; 2017 Apr; 201():91-99. PubMed ID: 28254481
[TBL] [Abstract][Full Text] [Related]
4. Preventive effects of berberine on glucocorticoid-induced osteoporosis in rats.
Xu D; Yang W; Zhou C; Liu Y; Xu B
Planta Med; 2010 Nov; 76(16):1809-13. PubMed ID: 20577944
[TBL] [Abstract][Full Text] [Related]
5. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
Khan MP; Mishra JS; Sharan K; Yadav M; Singh AK; Srivastava A; Kumar S; Bhaduaria S; Maurya R; Sanyal S; Chattopadhyay N
Phytomedicine; 2013 Nov; 20(14):1256-66. PubMed ID: 23928508
[TBL] [Abstract][Full Text] [Related]
6. Preventative effects of metformin on glucocorticoid-induced osteoporosis in rats.
Zhao J; Li Y; Zhang H; Shi D; Li Q; Meng Y; Zuo L
J Bone Miner Metab; 2019 Sep; 37(5):805-814. PubMed ID: 30706148
[TBL] [Abstract][Full Text] [Related]
7. Sclerostin Antibody Reverses Bone Loss by Increasing Bone Formation and Decreasing Bone Resorption in a Rat Model of Male Osteoporosis.
Li X; Ominsky MS; Villasenor KS; Niu QT; Asuncion FJ; Xia X; Grisanti M; Wronski TJ; Simonet WS; Ke HZ
Endocrinology; 2018 Jan; 159(1):260-271. PubMed ID: 29069393
[TBL] [Abstract][Full Text] [Related]
8. [The effects of glucocorticoid on expression of cannabinoid-1 receptors in osteoclasts from tibial proximal metaphysis of rats].
Liu SP; Chen J; Dai RC; Yang SM; Li JW; Wu XP; Liao EY
Zhonghua Nei Ke Za Zhi; 2009 Feb; 48(2):144-8. PubMed ID: 19549472
[TBL] [Abstract][Full Text] [Related]
9. Ginsenosides Rg3 attenuates glucocorticoid-induced osteoporosis through regulating BMP-2/BMPR1A/Runx2 signaling pathway.
Zhang X; Chen K; Wei B; Liu X; Lei Z; Bai X
Chem Biol Interact; 2016 Aug; 256():188-97. PubMed ID: 27387537
[TBL] [Abstract][Full Text] [Related]
10. Influence of glucocorticoid on bone in 3-, 6-, and 12-month-old rats as determined by bone mass and histomorphometry.
Ogoshi T; Hagino H; Fukata S; Tanishima S; Okano T; Teshima R
Mod Rheumatol; 2008; 18(6):552-61. PubMed ID: 18648735
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the therapeutic effects of yeast-incorporated gallium with those of inorganic gallium on ovariectomized osteopenic rats.
Ma Z; Fu Q
Biol Trace Elem Res; 2010 Jun; 134(3):280-7. PubMed ID: 19652924
[TBL] [Abstract][Full Text] [Related]
12. Risedronate prevents the loss of microarchitecture in glucocorticoid-induced osteoporosis in rats.
Dalle Carbonare L; Bertoldo F; Valenti MT; Zordan S; Sella S; Fassina A; Turco G; Realdi G; Lo Cascio V; Giannini S
J Endocrinol Invest; 2007 Oct; 30(9):739-46. PubMed ID: 17993765
[TBL] [Abstract][Full Text] [Related]
13. Vitamin K2 inhibits glucocorticoid-induced bone loss partly by preventing the reduction of osteoprotegerin (OPG).
Sasaki N; Kusano E; Takahashi H; Ando Y; Yano K; Tsuda E; Asano Y
J Bone Miner Metab; 2005; 23(1):41-7. PubMed ID: 15616893
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of necrostatin-1 on glucocorticoid-induced osteoporosis in rats.
Feng M; Zhang R; Gong F; Yang P; Fan L; Ni J; Bi W; Zhang Y; Wang C; Wang K
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():455-62. PubMed ID: 25220755
[TBL] [Abstract][Full Text] [Related]
15. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
[TBL] [Abstract][Full Text] [Related]
16. The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment.
Oxlund H; Ortoft G; Thomsen JS; Danielsen CC; Ejersted C; Andreassen TT
Bone; 2006 Aug; 39(2):244-52. PubMed ID: 16503210
[TBL] [Abstract][Full Text] [Related]
17. Short-term glucocorticoid treatment causes spinal osteoporosis in ovariectomized rats.
Böcker W; El Khassawna T; Bauer N; Brodsky K; Weisweiler D; Govindarajan P; Schlewitz G; Kampschulte M; Dürselen L; Thormann U; Szalay G; Schnettler R; Langheinrich AC; Heiss C
Eur Spine J; 2014 Nov; 23(11):2437-48. PubMed ID: 25077942
[TBL] [Abstract][Full Text] [Related]
18. Yeast-incorporated gallium promotes fracture healing by increasing callus bony area and improving trabecular microstructure on ovariectomized osteopenic rats.
Pei Y; Fu Q
Biol Trace Elem Res; 2011 Jun; 141(1-3):207-15. PubMed ID: 20446054
[TBL] [Abstract][Full Text] [Related]
19. Effects of glucocorticoid-induced osteoporosis on bone tissue of rats with experimental periodontitis.
Sousa LH; Moura EV; Queiroz AL; Val D; Chaves H; Lisboa M; Furlaneto F; Brito GA; Goes P
Arch Oral Biol; 2017 May; 77():55-61. PubMed ID: 28178585
[TBL] [Abstract][Full Text] [Related]
20. Tetramethylpyrazine Protects Against Glucocorticoid-Induced Apoptosis by Promoting Autophagy in Mesenchymal Stem Cells and Improves Bone Mass in Glucocorticoid-Induced Osteoporosis Rats.
Wang L; Zhang HY; Gao B; Shi J; Huang Q; Han YH; Hu YQ; Lu WG; Zhao ZJ; Liu BH; Jie Q; Yang L; Luo ZJ
Stem Cells Dev; 2017 Mar; 26(6):419-430. PubMed ID: 27917698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
